Digital Health Program Shows Promise for Young Cancer Survivors' Wellbeing

Can Digital Innovation Enhance AYA Survivorship Care?

The digital health intervention TOGETHER shows promising results in improving health-related quality of life for adolescent and young adult cancer survivors, according to a recent proof-of-concept analysis. This innovative 10-week program, designed specifically to address the unique needs of cancer survivors aged 18-39, demonstrated significant improvements across multiple patient-reported outcomes, particularly in emotional wellbeing and stress management capabilities. The intervention combines relaxation training, cognitive-behavioral therapy skills, and age-appropriate health education, all delivered via videoconference to facilitate peer support while maintaining accessibility. The analysis pooled data from four single-arm pilot studies conducted across multiple cancer centers in the United States, including the Moffitt Cancer Center, Robert H. Lurie Comprehensive Cancer Center, and the University of Arizona Cancer Center, as well as through national digital recruitment channels. The findings address a critical gap in survivorship care, as adolescent and young adult (AYA) cancer survivors typically report worse health-related quality of life than both their cancer-free peers and older cancer survivors, yet have been historically underrepresented in behavioral intervention research.

The TOGETHER intervention specifically targets stress management through a group-based, digital delivery format that aligns with AYA preferences and needs. The program consists of weekly two-hour sessions conducted over videoconference, where participants receive training in relaxation techniques, cognitive-behavioral coping strategies, and health education relevant to young adult cancer survivors. Participants were provided with a workbook and audio recordings of relaxation exercises to facilitate at-home practice. Sessions were facilitated by trained graduate-level counseling or clinical psychology trainees under supervision of the study principal investigators. The analysis included 51 AYA cancer survivors with an average age of 29 years, primarily female (78%) and White (69%), with lymphoma (32%), breast cancer (16%), and leukemia (14%) as the most common diagnoses. All participants had completed curative cancer treatment between one month and five years prior to enrollment, though those on maintenance hormone therapy were eligible. The intervention demonstrated strong retention with 76% of participants completing the post-intervention assessment, though attendance varied across the sample with an average of 6.1 sessions attended out of 10. The researchers employed multiple imputation strategies to account for missing data, strengthening the reliability of their findings despite the 24% attrition rate.

What Does the Evidence Say About Patient Outcomes?

The primary outcome of health-related quality of life, measured using the Functional Assessment of Cancer Therapy–General (FACT-G), showed significant improvement from pre-to-post intervention with a small effect size (g=0.32, p<0.001). Notably, between 51% and 59% of participants achieved clinically meaningful improvement, defined as an increase of at least 5 points on the FACT-G total score. When examining specific domains of quality of life, the most consistent improvements were observed in emotional and functional wellbeing, with effect sizes ranging from 0.25 to 0.96 across sensitivity analyses. Physical wellbeing showed significant improvement under some imputation approaches, while social wellbeing demonstrated less consistent change. Secondary outcomes revealed substantial improvements in participants' self-efficacy for stress management skills, particularly in their ability to relax at will, be assertive, and choose appropriate coping responses (effect sizes ranging from 0.41 to 1.02). Several adaptive coping strategies showed increased use following the intervention, including active coping, positive reframing, and acceptance, while maladaptive strategies like self-blame significantly decreased. Depression symptoms improved for many participants, with 51%-58% reporting clinically meaningful reductions. However, anxiety symptoms did not show consistent significant change across the sample, though 26%-35% of participants did achieve clinically meaningful improvement in anxiety.

What Limitations Should Inform Clinical Practice?

Despite the promising findings, several limitations warrant consideration when interpreting these results. The analysis pooled data from multiple single-arm pilot studies without comparison groups, making it impossible to definitively attribute changes to the intervention rather than other factors. The small sample size limited statistical power and precluded examination of potential moderators such as recruitment site or demographic factors. The requirement for internet or cellular connectivity may have limited generalizability to AYAs with fewer technological resources. The inclusion of participants with advanced disease, though they were not anticipating imminent treatment, may have introduced group differences that could not be adequately explored due to the sample size. Additionally, the time commitment required (two hours weekly for 10 weeks) likely contributed to attrition, suggesting that streamlining the intervention might improve engagement and completion rates. The researchers noted that the lack of significant improvement in anxiety symptoms contrasted with existing literature on behavioral stress management interventions, speculating that this might relate to the PROMIS Anxiety scale measuring generalized anxiety rather than cancer-specific anxiety, or to the societal-level stressors present during the data collection period (August 2021 to August 2024), which included the COVID-19 pandemic.

Could This Digital Approach Transform Future Survivorship Strategies?

The TOGETHER intervention represents a significant step forward in addressing the unmet needs of adolescent and young adult cancer survivors. Its digital, group-based format offers potential for widespread dissemination, and the focus on stress management skills provides AYAs with practical tools for navigating survivorship challenges. The proof-of-concept results support continued evaluation of the intervention's impact through larger, randomized controlled trials. For clinicians working with AYA cancer survivors, these findings highlight the potential value of incorporating structured behavioral interventions into survivorship care plans, particularly those that facilitate peer connection while building concrete coping skills. Could the integration of digital group-based interventions like TOGETHER become a standard component of comprehensive survivorship care for AYAs? How might future iterations of such interventions be tailored to better address anxiety symptoms specific to cancer-related concerns rather than generalized anxiety? What implementation strategies would best support the adoption of evidence-based eHealth interventions in diverse clinical settings serving AYA cancer survivors? These questions represent important directions for future research and clinical practice as the field continues to develop effective psychosocial support approaches for this unique survivor population.

Summary

A recent proof-of-concept analysis demonstrates that the TOGETHER digital health intervention significantly improves health-related quality of life for adolescent and young adult (AYA) cancer survivors aged 18-39. This 10-week program, delivered via videoconference, combines relaxation training, cognitive-behavioral therapy skills, and age-appropriate health education to address the unique needs of young cancer survivors. The analysis pooled data from 51 AYA survivors across four pilot studies conducted at multiple U.S. cancer centers. Results showed significant improvements in overall quality of life, with 51-59% of participants achieving clinically meaningful gains. The intervention particularly enhanced emotional and functional wellbeing, stress management self-efficacy, and adaptive coping strategies, while reducing depression symptoms and maladaptive coping behaviors. However, anxiety symptoms did not show consistent improvement across the sample. Despite limitations including the lack of control groups, small sample size, and 24% attrition rate, the findings support the potential of digital, group-based behavioral interventions for AYA survivorship care. The study addresses a critical gap, as AYA cancer survivors typically report worse quality of life than both cancer-free peers and older survivors, yet have been historically underrepresented in behavioral intervention research. The digital format offers promise for widespread dissemination and aligns with AYA preferences, though future research through randomized controlled trials is needed to definitively establish effectiveness and optimize implementation strategies for diverse clinical settings.